Pankti Reid to Arthritis, Rheumatoid
This is a "connection" page, showing publications Pankti Reid has written about Arthritis, Rheumatoid.
Connection Strength
1.698
-
Mortality Trends in Rheumatoid Arthritis: Zooming in on Interstitial Lung Disease. Ann Am Thorac Soc. 2021 12; 18(12):1953-1954.
Score: 0.701
-
Use of Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs and Cancer Risk. JAMA Netw Open. 2024 Nov 04; 7(11):e2446336.
Score: 0.215
-
JAK inhibitors and black box warnings: what is the future for JAK inhibitors? Expert Rev Clin Immunol. 2023 Jul-Dec; 19(11):1385-1397.
Score: 0.198
-
Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors. Drug Saf. 2023 11; 46(11):1049-1071.
Score: 0.197
-
Anticitrullinated peptide antibody epitope expansion and the HLA DRB1 'shared epitope' are less common in seropositive checkpoint inhibitor-induced inflammatory arthritis than in longstanding rheumatoid arthritis. RMD Open. 2023 06; 9(2).
Score: 0.195
-
Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis. Ann Rheum Dis. 2023 07; 82(7):920-926.
Score: 0.192